
India's innovation push falters with researchers denied timely funding
At the IIT, Paras is a research fellow, looking into solutions to a global public health crisis created by the spread of infectious diseases. His fellowship comes from the INSPIRE scheme, funded by India's Department of Science and Technology (DST).
But delays in the scheme's payment have meant that Paras was not able to pay the instalments on the laptop he bought for his research in 2022. His credit score plummeted, and his savings plans crashed.
Paras's parents are farmers in a drought-affected region of western India, and their income depends on a harvest that often fails. So, he has resorted to borrowing money from friends, including as recently as between August and December, he told Al Jazeera.
Paras is not alone. Al Jazeera spoke to nearly a dozen current and former fellows enrolled in top institutes across India under the Innovation in Science Pursuit for Inspired Research (INSPIRE) programme. The interviewees studied at institutions such as the IITs, a network of engineering and technology schools across the country, the Indian Institutes of Science Education and Research, another network.
All had gone from three to as long as nine months without a stipend.
The funding delays and procedural lapses have marred the fellowship and impaired their research capacity, they said.
Many researchers recently took to social media to complain, tagging Indian Prime Minister Narendra Modi and Minister of Science and Technology Jitendra Singh.
'For over a year now, many of us who are pursuing PhDs under DST-funded fellowships have not received our stipends,' Sayali Atkare, an INSPIRE fellow, wrote on LinkedIn. 'This has pushed many young researchers into severe financial and emotional stress.'
Last year, India ranked 39th in the Global Innovation Index of 133 countries, up one spot from the year prior. It leads lower-middle-income countries like Vietnam and the Philippines in innovation. China leads upper-middle-income countries and is followed by Malaysia and Turkiye.
The federal government termed the ranking an 'impressive leap' in a news release. It said that India's 'growing innovation potential has been supported by government initiatives that prioritise technological advancement, ease of doing business, and entrepreneurship'.
At a federal government conference in April, Modi boasted of India's growing research acumen. Under his leadership in the past decade, the government has doubled its gross spending on research and development from 600 billion rupees ($7.05bn) to more than 1,250 billion rupees ($14.7bn), while the number of patents filed has more than doubled – from 40,000 to more than 80,000.
The numerous steps taken by the government – like doubling of expenditure on R&D, doubling of patents filed in India, creation of state-of-the art research parks and research fellowships and facilities – ensure 'that talented individuals face no obstacles in advancing their careers', Modi said.
However, an analysis of government documents, budgets and interviews with researchers reveals that the government is more focused on commercial research, primarily product development led by start-ups and big corporations. It is offering little funding for research conducted at the country's premier universities.
For instance, in the current financial year, 70 percent of the Science and Technology Department's annual budget has been allocated to a scheme under which interest-free loans are provided to private companies conducting research in sunrise domains, such as semiconductors.
At the same time, the government has made misleading statements about its investments in the country's research institutes, including with schemes like the INSPIRE fellowship, where funds have actually been cut instead of being increased as touted by the government.
Poor pay, funding delays
The INSPIRE scheme offers PhD and faculty fellowships to 'attract, attach, retain and nourish talented young scientific Human Resource for strengthening the R&D [research and development] foundation and base'.
The fellowships are offered to top-ranking postgraduate students and doctoral researchers to conduct research in areas from agriculture, biochemistry, neuroscience and cancer biology to climate science, renewable energy and nanotechnology.
Under the scheme, PhD fellows are to receive 37,000 rupees ($435.14) to 42,000 rupees ($493.94) per month for living expenses and 20,000 rupees ($235.21) annually for research-related costs, such as paying for equipment or work-related travel.
Faculty fellows are offered teaching positions with a monthly salary of 125,000 rupees ($1,470) and an annual research grant of 700,000 rupees ($8,232).
In the year 2024-25, 653 fellows were enrolled in the PhD fellowship, and 85 in the faculty fellowship programme.
'I couldn't attend an important annual meeting in our field because it required travel, and I was not sure if I would get my allowance,' a faculty fellow at an institute in eastern India said. He has not received his payments since September 2024.
Atkare, the PhD student who wrote about the government's failure on LinkedIn, also wrote, 'We've made endless phone calls, written countless emails – most of which go unanswered or are met with vague responses. Some officials even respond rudely.'
Another INSPIRE PhD fellow told us of a running joke: 'If they pick up the phone, you can buy a lottery ticket that day. It's your lucky day.'
In May, DST Secretary Abhay Karandikar accepted that there were funding delays and said that they would soon be resolved.
Karandikar told the Hindu newspaper that he was 'aware' of the disbursement crisis but said that from June 2025, all scholars would get their money on time. 'All problems have been addressed. I don't foresee any issue in the future,' he said.
Al Jazeera requested a comment from the science and technology minister, the DST secretary and the head of the department's wing that implements the INSPIRE scheme, but has not received a response.
Dodgy math
In January, the federal government folded three R&D-related schemes to start Vigyan Dhara or 'the flow of science' to ensure 'efficiency in fund utilisation'. The INSPIRE scheme had been funded under one of those schemes.
But instead of efficiency, there has been chaos.
Under Vigyan Dhara, DST asked institutes to set up new bank accounts, leading to delays in payments for INSPIRE fellowships.
New Delhi also said that it had 'significantly increased' funding for the Vigyan Dhara scheme, from 3.30 billion rupees ($38.39m) in the last financial year to 14.25 billion rupees ($167.58m) in the current financial year.
However, that math was incomplete. The 3.30 billion rupees ($38.39m) is what the government earmarked for the scheme, which was only launched in the last quarter of the fiscal year. The budget for the full fiscal year of the three schemes that Vigyan Dhara replaced amounted to 18.27 billion rupees ($214.93m). So, in effect, the current budget saw a 22 percent decrease in allocation from 18.27 billion rupees to 14.25 billion rupees ($167.58m).
Overall, budget for Vigyan Dhara's constituent schemes reduced 67.5 percent from 43.89 billion rupees ($513.2m) in financial year 2016-17 to 14.25 billion rupees ($167.6m) in financial year 2025-26.
DST officials did not respond to Al Jazeera's query requesting clarification of Vigyan Dhara's budgetary allocations.
Commercialisation of research
On the other hand, the Indian government earmarked 200 billion rupees ($2.35bn) for the new Research, Development and Innovation (RDI) scheme targeting the private sector.
This money is part of a larger 1-trillion-rupee ($11.76bn) corpus previously announced by India's finance minister to provide long-term financing at low or no interest rates.
These changes in schemes are intended to make India a 'product nation', get more patents filed in India, and curb the brain drain, as Union Minister Aswini Vaishnaw and DST officials explain in different videos.
But the plight of the researchers at state-run organisations remains unaddressed.
'The government throws around big terms but those toiling in laboratories are suffering,' said Lal Chandra Vishwakarma, president of All-India Research Scholars Association.
'Stipends should be similar to salaries of central government employees. Fellows should get their money every month without fail,' he said.
In the current scenario, most fellows Al Jazeera spoke to said that they would prefer a fellowship abroad.
'It's not just about funds but the ease of research, which is much better in Europe and USA. We get so much staff support there. In India, you get none of that,' said a professor at an IIT, who supervises an INSPIRE PhD fellow who faced funding issues.
While the private sector is being heavily financed, researchers told us they downplay their funding costs as that improves their chances of landing government research projects.
'Cutting-edge research is so fast, if we lose the first few years due to cost-cutting, we are behind our colleagues abroad,' the IIT professor said.
'Once we submit necessary documents, like annual progress reports, DST takes at least three months to release the next instalment. It's usual,' said a PhD fellow who is a theoretical mathematician.
'Right now, I would say only people with privilege [and high-income backgrounds] should be in academia. Not because that's how it should be, but because for others, it's just so hard,' the IIT professor said.
*Al Jazeera has changed names to protect the identity of interviewees.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Al Jazeera
2 days ago
- Al Jazeera
What is the Nipah virus and is it spreading in southern India?
On July 12, a new deadly Nipah virus infection was confirmed in a 52-year-old man in the Palakkad district of Kerala, marking the tenth instance of Nipah virus spillover (transmission of the pathogen from animals to humans) in the southern Indian state since 2018. This year alone, Kerala has reported four Nipah cases, including two deaths, all within a 50km (30-mile) radius, on the border of the Malappuram and Palakkad districts. The state remains on high alert, with 675 people under surveillance across five districts. Here is what we know about the Nipah virus, its symptoms and how authorities are containing it. What is the Nipah virus? Nipah virus (NiV) is a highly pathogenic zoonotic virus (a virus that can be transmitted from animals to humans) which causes death in 40 to 75 percent of human infected cases. Alongside the Hendra virus, which is found in Australia, NiV is one of the most notable viruses from the henipavirus genus of the paramyxovirus family, responsible for a range of neurological – often respiratory – diseases in humans and animals. Fruit bats of the Pteropodidae family, ubiquitous across Oceania, South and Southeast Asia, and sub-Saharan Africa, are natural reservoirs of the virus, meaning the virus naturally lives and reproduces in these mammals without causing them any harm. The spillover of the virus to humans can happen directly or via intermediate hosts such as pigs or horses, which come into contact with humans. What are the symptoms of the Nipah virus? According to the World Health Organization (WHO), human NiV infections range from asymptomatic infection to acute respiratory infection, seizures and fatal encephalitis (inflammation of the brain). The clinical presentation of NiV infection is neurological, affecting the central nervous system and resulting in acute encephalitis syndrome (AES), characterised by seizures, confusion and loss of consciousness. When the disease advances, it can cause damage to the lungs and can lead to life-threatening acute respiratory distress syndrome (ARDS). The incubation period of the virus is believed to be four to 14 days. Where have there been Nipah virus outbreaks before? The first human NiV infection was recorded in 1998, when pig farmers and butchers from Malaysia and Singapore contracted the virus from infected pigs. The outbreak affected more than 250 individuals and caused more than 100 deaths. There have been subsequent, almost annual outbreaks in Bangladesh since 2001, with human infection traced to the consumption of date palm sap contaminated with urine or saliva from infected fruit bats. In 2014, NiV infections in the Philippines were associated with the slaughter of horses and consumption of infected horse meat. India has reported two outbreaks in West Bengal in 2001 and 2007. In 2018, South India reported its first NiV outbreak in Kerala, when 19 confirmed cases led to 17 deaths. Since then, Kerala has reported NiV spillovers almost every year. What has happened in Kerala? Although Kerala has recorded 10 instances of NiV spillover since 2018, only two of them turned into outbreaks with instances of human-to-human spread. 'We are now reporting single cases of Nipah infections rather than a cluster or outbreak like in 2018,' Thekkumkara Surendran Anish, nodal officer at the Kerala One Health Centre for Nipah Research and Resilience, said. The last six NiV infections in the state have been single-case spillovers with no human-to-human transmission. The recent uptick in recorded cases is down to the strengthened surveillance system in the state, according to Anish. 'Thousands of people die in India every year due to AES or ARDS, [where] we don't know the cause. NiV, in fact, is not a common cause for respiratory and encephalitis syndromes,' he said. 'But in Kerala, because the entire health system is prioritising Nipah, we are detecting more Nipah infections.' At the same time, it is concerning that all four NiV infections in 2025 were reported in a small timeframe within a small area, Anish added. 'Four independent spillover events within a couple of months in a 50km radius suggest a very high presence of infected bats and the virus in the area. 'What it tells us is that in certain geospatial locations in Kerala, there is a high likelihood of Nipah spillovers, primarily because the bats in those localities seem to be highly infectious for a short period during the year.' What is causing the spread of the Nipah virus in Kerala? Unlike in Bangladesh, where there was a dedicated channel for the virus to spill over to humans (contaminated date palm sap), there is no obvious source in Kerala – or, at least, the 'spillover mechanism' so far remains unclear. 'We don't know the exact spillover mechanism, but it seems to be highly sporadic in Kerala. For example, you unknowingly come in contact with an infected bat or its droppings,' Anish said. The commonly accepted cause is spillover from the human consumption of fruits contaminated by bat saliva or urine. However, virological examination of bat-bitten fruits has yielded negative results so far. A new paper by the Indian Council of Medical Research suggests the virus may be airborne. 'Disease-causing microbes have different routes of transmission to reach and infect human hosts,' Thekkekara Jacob John, one of the authors of the paper, and an emeritus professor at the Christian Medical College, Vellore, said. 'One of them is airborne transmission, like in Tuberculosis, whereby microbes float in the air for longer distances and are inhaled far away from the source.' The authors of the paper believe their hypothesis 'accommodates the rare but recurrent spillovers of NiV in Kerala', where there are no mechanical vectors for the virus, such as in Bangladesh or Malaysia. What are the authorities doing to contain the Nipah virus in Kerala? So far, Kerala has been successful in containing the spread of the virus using trace-and-test procedures. Across 10 'spillover events', the case count stands at just 37 infected individuals. The key to this is a strong surveillance system, said Anish. 'When a Nipah case is established, all primary contacts of the patient are immediately traced and monitored under house quarantine. If they test positive for the virus, we immediately start antiviral treatment,' he said. The prophylactic treatment of 'primary contacts' with broad-spectrum antiviral drugs has helped reduce mortality. 'In our experience, if we can treat Nipah early, it can definitely be cured,' Anish said. 'Syndromic surveillance is another crucial aspect, whereby, in hospitals across the state, any patient presenting with AES or ARDS is tested for Nipah,' Anish said. Kerala has been steadily improving its health system. The state now has four labs capable of conducting RT-PCR (Reverse Transcription Polymerase Chain Reaction) tests for detecting active NiV infections. 'It all comes down to political commitment,' Anish said. 'The state ensures that efforts of the entire health system remain focused on Nipah outbreaks.' What is the treatment for Nipah virus? Is there a vaccine in development? The WHO has identified Nipah as a priority disease for its Research and Development Blueprint – a global strategy and preparedness plan for epidemics. The University of Oxford's NiV vaccine, which began in-human trials in January, was granted support from the Priority Medicines (PRIME) scheme of the European Medicines Agency (EMA) in June. However, there are no drugs yet available that specifically target NiV infection. Since there are no approved treatment protocols for NiV, and due to the high risk of mortality, doctors have used broad-spectrum antivirals. Ribavirin is the antiviral of choice, as it has been found to be effective against NiV infections in humans on several occasions. During a 2023 outbreak in Kerala, early application of the antiviral Remdesivir resulted in an improved case fatality rate. Monoclonal antibodies (copies of antibodies, created in a laboratory) have also been used to prevent severe disease manifestations in high-risk individuals. How can we avoid zoonotic viruses like the Nipah virus? According to Anish, NiV is a model case study for a 'one health' approach to combating high-threat pathogens. The one health approach recognises the fact that human health is interlinked with the health of animals and the environment. '[One health] is a combination of three things – human health, animal health and environment health,' Anish said. 'You have to tackle all these things to reduce the chances of zoonotic spillovers such as Nipah.' Approximately 60 percent of emerging human pathogens are zoonoses, transmitted from animals to humans. Ecological disruption and the spread of human populations into wildlife habitats are primary causes for the emergence of these zoonotic viruses. Climate change is another growing concern, with rising temperatures attributed to influencing infections, viral load and human-animal interactions.


Al Jazeera
15-07-2025
- Al Jazeera
Video: SpaceX capsule returns to earth after 20-day mission
SpaceX capsule returns to earth after 20-day mission NewsFeed Astronauts from India, Poland, Hungary and the United States returned to Earth early Tuesday after the 20-day SpaceX Axiom Mission 4 to the International Space Station. They parachuted into the Pacific Ocean off the coast of Southern California. Video Duration 00 minutes 38 seconds 00:38 Video Duration 02 minutes 56 seconds 02:56 Video Duration 01 minutes 27 seconds 01:27 Video Duration 01 minutes 58 seconds 01:58 Video Duration 00 minutes 54 seconds 00:54 Video Duration 02 minutes 20 seconds 02:20 Video Duration 01 minutes 10 seconds 01:10


Al Jazeera
03-07-2025
- Al Jazeera
Is ChatGPT hurting our critical thinking skills?
The Take An MIT study finds ChatGPT may be hurting critical thinking skills. How do you use AI tools while protecting your brain? Are AI chatbots dulling our brains? A new MIT study suggests critical thinking skills are at risk from tools like ChatGPT. What does the science say happens to brains that rely on AI? And how can you use AI tools while protecting your ability to think for yourself? Video Duration 22 minutes 45 seconds 22:45 Video Duration 22 minutes 02 seconds 22:02 Video Duration 21 minutes 00 seconds 21:00 Video Duration 22 minutes 49 seconds 22:49 Video Duration 21 minutes 18 seconds 21:18 Video Duration 21 minutes 49 seconds 21:49 Video Duration 24 minutes 29 seconds 24:29